Michael Braun

8.3k citations

156 papers · 2.9k indexed · 1 hit paper · h-index 29

Impact in

Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics

Papers in ⓘ

Cancer Research 60
- Breast Cancer Treatment Studies 51
Oncology 93
- Colorectal Cancer Treatments and Studies 25
- HER2/EGFR in Cancer Research 17
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Surgical Treatments 13
- Colorectal Cancer Screening and Detection 12

Co-authors: Michel Seymour (12 shared papers)Walther Kuhn (24 shared papers)Nadia Harbeck (41 shared papers)Hans H. Schild (10 shared papers)Martin Pölcher (18 shared papers)Christiane Kühl (7 shared papers)Philip Quirke (7 shared papers)Julian Adlard (4 shared papers)
Journals: Journal of Clinical Oncology (22 papers)Annals of Oncology (14 papers)Cancer Research (6 papers)Cancers (4 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)
Partner nations: Germany United Kingdom Switzerland

In The Last Decade

Michael Braun

148 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response 2022 · 136 citations

Peers

Countries citing papers authored by Michael Braun

Since Specialization

Citations

This map shows the geographic impact of Michael Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Braun more than expected).

Fields of papers citing papers by Michael Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Braun. The network helps show where Michael Braun may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Braun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Braun Line = papers co-authored together Michael Braun links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial Journal of Clinical Oncology ·Michael Braun, Susan D. Richman, Philip Quirke, Catherine Daly, Julian Adlard, Faye Elliott, Jennifer H. Barrett, Peter Selby, Angela Meade, Richard Stephens, Mahesh Parmar, Michel Seymour	2008	217
2	Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response Annals of Oncology ·Sibylle Loibl, Andreas Schneeweiß, Jens Huober, Michael Braun, Julia Rey, Jens‐Uwe Blohmer, Jenny Furlanetto, D M Zahm, Claus Hanusch, Jörg Thomalla, Christian Jackisch, Peter Staib, Theresa Link, Kerstin Rhiem, Christine Solbach, Peter A. Fasching, Valentina Nekljudova, Carsten Denkert, Michael Untch Hit paper breakdown →	2022	136
3	Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care Supportive Care in Cancer ·Sven Simons, Susanne Ringsdorf, Michael Braun, Ulrich Mey, P Schwindt, Yon Ko, Ingo Schmidt‐Wolf, Walther Kuhn, Ulrich Jaehde	2010	108
4	Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial Journal of Clinical Oncology ·Michael Braun, Susan D. Richman, Lindsay C Thompson, Catherine Daly, Angela Meade, Julian Adlard, James M. Allan, Mahesh Parmar, Philip Quirke, Michel Seymour	2009	99
5	Durvalumab improves long-term outcome in TNBC: results from the phase II randomized GeparNUEVO study investigating neodjuvant durvalumab in addition to an anthracycline/taxane based neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC). Journal of Clinical Oncology ·Sibylle Loibl, Andreas Schneeweiß, Jens Huober, Michael Braun, Julia Rey, Jens‐Uwe Blohmer, Jenny Furlanetto, Dirk M. Zahm, Claus Hanusch, Jörg Thomalla, Christian Jackisch, Peter Staib, Theresa Link, Kerstin Rhiem, Christine Solbach, Peter A. Fasching, Nicole Burchardi, Carsten Denkert, Michael Untch	2021	87
6	Pre-operative staging of breast cancer with breast MRI: One step forward, two steps back? The Breast ·Christiane Kühl, W. Kühn, Michael Braun, Hans H. Schild	2007	84
7	Balancing the efficacy and toxicity of chemotherapy in colorectal cancer Therapeutic Advances in Medical Oncology ·Michael Braun, Michel Seymour	2010	83
8	Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer European Journal of Cancer ·F Otto, Peter Schmid, Andréas Mackensen, U. Wehr, Alexander Seiz, Michael Braun, Chris Galanos, R Mertelsmann, R. Engelhardt	1996	82
9	Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress JNCI Journal of the National Cancer Institute ·Kerstin Hermelink, Varinka Voigt, Judith Kaste, Franziska Neufeld, Rachel Wuerstlein, Markus Bühner, Karin Münzel, Dorothea Rjosk-Dendorfer, Susanne Grandl, Michael Braun, Franz Edler von Koch, Kristin Härtl, Stephan Hasmüller, Ingo Bauerfeind, Gerlinde Debus, Peter Herschbach, Nadia Harbeck	2015	70
10	Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients JNCI Journal of the National Cancer Institute ·Kerstin Hermelink, Markus Bühner, Philipp Sckopke, Franziska Neufeld, Judith Kaste, Varinka Voigt, Karin Münzel, Rachel Wuerstlein, Nina Ditsch, Karin Hellerhoff, Dorothea Rjosk-Dendorfer, Michael Braun, Franz Edler von Koch, Kristin Härtl, Stephan Hasmüller, Ingo Bauerfeind, Gerlinde Debus, Peter Herschbach, Sven Mahner, Nadia Harbeck	2017	69
11	Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma Cancer Immunology Immunotherapy ·Martin Pölcher, Michael Braun, Nicolaus Friedrichs, Christian Rudlowski, Eva Bercht, Rolf Fimmers, Axel Sauerwald, Mignon-Denise Keyver-Paik, Kirsten Kübler, Reinhard Büttner, Walther Kuhn, Juan-José Hernando	2010	68
12	Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy Radiotherapy and Oncology ·Cristoforo Simonetto, Markus Eidemüller, Aurelié Gaasch, Montserrat Pazos, Stephan Schönecker, D. Reitz, Stefan Kääb, Michael Braun, Nadia Harbeck, Maximilian Niyazi, Claus Belka, Stefanie Corradini	2018	68
13	Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy Tumor Biology ·Oliver J. Stoetzer, Debora M.I. Fersching, Christoph Salat, Oliver Steinkohl, Christian J. Gabka, Ulrich Hamann, Michael Braun, Axel‐Mario Feller, Volker Heinemann, Barbara Siegele, Dorothea Nagel, Stefan Holdenrieder	2012	68
14	Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases Cancers ·Stefanie Corradini, D. Reitz, Montserrat Pazos, Stephan Schönecker, Michael Braun, Nadia Harbeck, Christiane Matuschek, Edwin Bölke, Ute Ganswindt, Filippo Alongi, Maximilian Niyazi, Claus Belka	2019	66
15	Influence of preoperative MRI on the surgical management of patients with operable breast cancer Breast Cancer Research and Treatment ·Michael Braun, Martin Pölcher, Simone Schrading, Oliver Zivanovic, Theresa Kowalski, Uta Flucke, C Leutner, Tong-Wong Park-Simon, Christian Rudlowski, Walther Kuhn, Christiane Kühl	2007	63
16	Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-α for relapsed metastatic ovarian cancer The Lancet Oncology ·Juan José Hernando, Tjoung‐Won Park, Hans‐Peter Fischer, Oliver Zivanovic, Michael Braun, Martin Pölcher, U. Grünn, C Leutner, Bernd Pötzsch, Walther Kuhn	2007	53
17	Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases Breast Cancer Research and Treatment ·Michael Braun, Uta Flucke, Manuel Debald, Gisela Walgenbach-Bruenagel, Klaus‐Jürgen Walgenbach, Tobias Höller, Martin Pölcher, Matthias Wolfgarten, Axel Sauerwald, Mignon Keyver-Paik, Marietta Kühr, Reinhard Büttner, Walther Kuhn	2007	52
18	Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study Psycho-Oncology ·Varinka Voigt, Franziska Neufeld, Judith Kaste, Markus Bühner, Philipp Sckopke, Rachel Wuerstlein, Karin Hellerhoff, Anikó Sztrókay-Gaul, Michael Braun, Franz Edler von Koch, Eliane Silva-Zürcher, Stephan Hasmüller, Ingo Bauerfeind, Gerlinde Debus, Peter Herschbach, Sven Mahner, Nadia Harbeck, Kerstin Hermelink	2016	51
19	Combined Transvaginal B-Mode and Color Doppler Sonography for Differential Diagnosis of Ovarian Tumors: Results of a Multivariate Logistic Regression Analysis Gynecologic Oncology ·M. Schelling, Michael Braun, Walther Kuhn, Gerhard Bogner, Robert Gruber, J. Gnirs, K. T. M. Schneider, Kurt Ulm, Stefan Rutke, Alf Staudach	2000	50
20	Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort Annals of Oncology ·Simone Schrodi, Michael Braun, A Andrulat, Nadia Harbeck, Sven Mahner, Marion Kiechle, E Klein, Andreas Schnelzer, Christian Schindlbeck, Ingo Bauerfeind, G. Schubert-Fritschle, Valentina Nekljudova, Doris Mayr, Wilko Weichert, Carsten Denkert, Sibylle Loibl, Jutta Engel	2021	46

About Michael Braun

Michael Braun is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Pathology and Forensic Medicine, having authored 156 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (51 papers), Colorectal Cancer Treatments and Studies (25 papers), HER2/EGFR in Cancer Research (17 papers), Cancer Treatment and Pharmacology (14 papers), Colorectal Cancer Surgical Treatments (13 papers), Colorectal Cancer Screening and Detection (12 papers), Advanced Breast Cancer Therapies (12 papers) and Breast Lesions and Carcinomas (12 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (770 citations), Family Practice (84 citations), Pathology and Forensic Medicine (436 citations) and Geriatrics and Gerontology (77 citations). Michael Braun has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Michel Seymour, Walther Kuhn, Nadia Harbeck, Hans H. Schild, Martin Pölcher, Christiane Kühl, Philip Quirke, Julian Adlard, Susan D. Richman and Mahesh Parmar. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancers and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact